Anticanceragent 250 (compound 104) exhibits antitumor activity by inducing cell apoptosis, slowing proliferation, and degrading key oncogenic proteins such as aRaf and CDK4, without triggering a heat shock response.
Target:
Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
